Cost Effectiveness of Whole Population BRCA Genetic Screening for Cancer Prevention in Israel | Citedby Results | Cancer Prevention Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Cost Effectiveness of Whole Population BRCA Genetic Screening for Cancer Prevention in Israel

Cancer Prev Res (Phila) (2021) 14 (4): 455–462.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Cost Effectiveness of Genomic Population Health Screening in Adults: A Review of Modeling Studies and Future Directions

Robert S Wildin

The Journal of Applied Laboratory Medicine (2024) 9 (1): 92.

Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review

Sook Pin Goh
Siew Chin Ong
Jue Ern Chan

BMC Cancer (2024) 24 (1)

Carrier screening program for BRCA1/BRCA2 pathogenic variants among Ashkenazi Jewish women in Israel: An observational study

Rotem Greenberg
Efrat Aharonov-Majar
Ofer Isakov
Samah Hayek
Naama Elefant
Ran D. Balicer
Adi Berliner Senderey
Shay Ben-Shachar

Genetics in Medicine Open (2023) 1 (1): 100824.

Economic evaluations of predictive genetic testing: A scoping review

Qin Xi
Shihan Jin
Stephen Morris
Katriina Aalto-Setala

PLOS ONE (2023) 18 (8): e0276572.

Privacy and utility of genetic testing in families with hereditary cancer syndromes living in three countries: the international cascade genetic screening experience

Sivia Barnoy
Efrat Dagan
Sue Kim
Maria Caiata-Zufferey
Maria C. Katapodi

Frontiers in Genetics (2023) 14

A review of the cost-effectiveness of genetic testing for germline variants in familial cancer

Srinivas Teppala
Brent Hodgkinson
Sandi Hayes
Paul Scuffham
Haitham Tuffaha

Journal of Medical Economics (2023) 26 (1): 19.

Combinatorial batching of DNA for ultralow-cost detection of pathogenic variants

Ulrik Kristoffer Stoltze
Christian Munch Hagen
Thomas van Overeem Hansen
Anna Byrjalsen
Anne-Marie Gerdes
Victor Yakimov
Simon Rasmussen
Marie Bækvad-Hansen
David Michael Hougaard
Kjeld Schmiegelow
Henrik Hjalgrim
Karin Wadt
Jonas Bybjerg-Grauholm

Genome Medicine (2023) 15 (1)

Missed opportunities in the real-world genetic testing in BRCA gene variant carriers with cancers meeting NCCN criteria

Sarah S. Lee
Pournami Rajeev
Skyler Finning
Cheongeun Oh
Bhavana Pothuri

Gynecologic Oncology (2023) 170: 32.

CDH1 germline mutations in families with hereditary lobular breast cancer

Antonia Girardi
Francesca Magnoni
Elisa Vicini
Andriana Kouloura
Carlo La Vecchia
Paolo Veronesi
Giovanni Corso

European Journal of Cancer Prevention (2022) 31 (3): 274.

Overview on population screening for carriers with germline BRCA mutation in China

Huijun Lei
Min Zhang
Luyao Zhang
Kari Hemminki
Xiao-jia Wang
Tianhui Chen

Frontiers in Oncology (2022) 12

Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies

Rachel Michaelson-Cohen
Matan J. Cohen
Carmit Cohen
Dan Greenberg
Amir Shmueli
Sari Lieberman
Ariela Tomer
Ephrat Levy-Lahad
Amnon Lahad

Cancers (2022) 14 (24): 6113.

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country

Marina Lourenção
Julia Simões Correa Galendi
Henrique de Campos Reis Galvão
Augusto Perazzolo Antoniazzi
Rebeca Silveira Grasel
André Lopes Carvalho
Edmundo Carvalho Mauad
Jorge Henrique Caldeira de Oliveira
Rui Manuel Reis
Olena Mandrik
Edenir Inêz Palmero

Frontiers in Oncology (2022) 12

Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis

Nadav Michaan
Moshe Leshno
Yoni Cohen
Tamar Safra
Shira Peleg-Hasson
Ido Laskov
Dan Grisaru

Reproductive Biology and Endocrinology (2021) 19 (1)